Developing Glycan-Based Antiviral Prophylactics to Prevent the Spread of COVID-19 and Other Respiratory Infections
- Funded by Canadian Institutes of Health Research (CIHR)
- Total publications:0 publications
Grant number: 202011CGV
Grant search
Key facts
Disease
COVID-19Start & end year
20202023Known Financial Commitments (USD)
$398,871Funder
Canadian Institutes of Health Research (CIHR)Principal Investigator
N/A
Research Location
CanadaLead Research Institution
Queen's UniversityResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Prophylactic use of treatments
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable